Vanda Pharma (VNDA.US) Stock Community - Hot Topic Discussions - Longbridge

Quote List Quote List

Event Tracking

Oct29

Vanda Pharma released FY2025 9 Months Earnings on October 29 After-Market EST, actual revenue USD 158.89 M, actual EPS USD -1.3473

23:00

Vanda Pharma released FY2025 Q3 earnings on October 29 After-Market EST, actual revenue USD 56.26 M (forecast USD 58.73 M), actual EPS USD -0.3822 (forecast USD -0.4533)

23:00

Vanda Pharmaceuticals Reports Q3 2025 Earnings and Updates Revenue Guidance

20:02

Oct22

Vanda Pharma to Release FY2025 Q3 Earnings on October 29 After-Market EST, Forecast Revenue USD 58.73 M, EPS USD -0.4533

00:05

Oct2

Analyst Upgrades Vanda's Stock Rating to Buy

10:26

Aug21

Vanda Pharmaceuticals Requests FDA Commissioner Review Previous Director's Decision

21:01

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 56.26 M, Net Income -22.59 M, EPS -0.3822

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 52.59 M, Net Income -27.21 M, EPS -0.4611

May7

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 50.04 M, Net Income -29.49 M, EPS -0.5039

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More